scholarly article | Q13442814 |
P2093 | author name string | Chunhua Li | |
Nan Li | |||
Rui Huang | |||
Jinyan Wang | |||
Zhidong Liu | |||
Jiawei Li | |||
Lingling Ding | |||
Dongli Qi | |||
Jiaxin Pi | |||
Shaozi Yao | |||
P2860 | cites work | Combination versus sequential single agent chemotherapy for metastatic breast cancer | Q24201726 |
Single agent versus combination chemotherapy for metastatic breast cancer | Q24241459 | ||
A high-performance nanobio photocatalyst for targeted brain cancer therapy | Q33606437 | ||
Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways | Q33769748 | ||
Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo | Q33895607 | ||
Global patterns of cancer incidence and mortality rates and trends | Q34127168 | ||
Salvianolic Acid B, a potential chemopreventive agent, for head and neck squamous cell cancer | Q34442838 | ||
Cardioprotective effect of salvianolic acid B against arsenic trioxide-induced injury in cardiac H9c2 cells via the PI3K/Akt signal pathway | Q34497465 | ||
Folate-mediated delivery of macromolecular anticancer therapeutic agents | Q34804841 | ||
Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy | Q35029953 | ||
Anticancer potential of curcumin: preclinical and clinical studies. | Q35101413 | ||
Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles | Q35149949 | ||
Hydrothermal synthesis of titanium dioxide nanoparticles: mosquitocidal potential and anticancer activity on human breast cancer cells (MCF-7). | Q35856432 | ||
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy | Q36093923 | ||
The biological chemistry of folate receptors | Q36113832 | ||
Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. | Q36892760 | ||
Pharmacokinetics and biodistribution of nanoparticles | Q37210459 | ||
Current progress of research on pharmacologic actions of salvianolic acid B. | Q37997977 | ||
Upconverting nanoparticles with a mesoporous TiO₂ shell for near-infrared-triggered drug delivery and synergistic targeted cancer therapy | Q38958520 | ||
Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K/Akt signaling pathway | Q38986865 | ||
Synthesis and characterisation of biologically compatible TiO2 nanoparticles. | Q39001887 | ||
Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia | Q39023471 | ||
Salvianolic acid B induces apoptosis in human glioma U87 cells through p38-mediated ROS generation | Q39127699 | ||
An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles | Q39673314 | ||
Estrogen and progestin regulate HIF-1alpha expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway. | Q39872542 | ||
Surface chemistry influences cancer killing effect of TiO2 nanoparticles | Q39978818 | ||
Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways | Q40152110 | ||
Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin. | Q40185330 | ||
Curcumin inhibits the formation of capillary-like tubes by rat lymphatic endothelial cells | Q40188430 | ||
Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis | Q40517197 | ||
Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin | Q42092827 | ||
Molecular mechanisms of anti-angiogenic effect of curcumin | Q42809823 | ||
Blood compatibility and in vitro transfection studies on cationically modified pullulan for liver cell targeted gene delivery | Q43281943 | ||
Effects of glutamate transporter inhibitors on the antitumor activity of doxorubicin | Q44243346 | ||
Cardiac oxidative damage in mice following exposure to nanoparticulate titanium dioxide | Q44771797 | ||
Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles. | Q53060157 | ||
Induction of cytotoxicity by photoexcited TiO2 particles | Q68090484 | ||
Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin | Q81270631 | ||
Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1 | Q83311734 | ||
Synthesis of TiO2 nanocrystals with a high affinity for amine organic compounds | Q84447047 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nanoparticle | Q61231 |
nanocarrier | Q17153796 | ||
myocardial damage | Q21112456 | ||
curcumin | Q312266 | ||
salvianolic acid b | Q27275057 | ||
TiO2 nanoparticle | Q125311943 | ||
P304 | page(s) | 5709-5727 | |
P577 | publication date | 2016-11-02 | |
P1433 | published in | International Journal of Nanomedicine | Q6051502 |
P1476 | title | Salvianolic acid B protects against myocardial damage caused by nanocarrier TiO2; and synergistic anti-breast carcinoma effect with curcumin via codelivery system of folic acid-targeted and polyethylene glycol-modified TiO2 nanoparticles | |
P478 | volume | 11 |